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ABSTRACT:
Introduction:  Central giant cell granuloma (CGCG)
is a benign aggressive destructive osteolytic lesion of
osteoclastic origin. The central giant cell granuloma is often
found in the mandible, anterior to the first molars. It most
commonly occurs in patients under the age of 30, with a clear
female prevalence
Purpose: To present a case of CGCG of the lower jaw
in Department of Oral and maxillofacial surgery, University
Hospital ‘St Anna’. Although en bloc resection provides the
lowest recurrence rate, only a few single case reports describe
the use of this technique followed by reconstruction with
autogenous bone grafts.
Material and methods: The medical history of a 28
years patient with a large central giant cell granuloma in the
mandible. Biopsy specimen taken from the lesion showed
CGCG followed by curettage with peripheral ostectomy with
preservation of the continuity of the mandible.
Result: At the 1-year clinical and radiological follow
up there was no sign of recurrence.
Conclusion: After complete healing of the graft,
prosthetic rehabilitation with implants will be perfomed. This
allows the best functional and aesthetic results.
Key words: central giant cell granuloma, autogenous
bone grafts, reconstruction
INTRODUCTION:
The central giant-cell reparative granuloma(CGCRG)
has been defined as a localized benign but sometimes
aggressive osteolytic proliferation consisting of fibrous tissue
with hemorrhage and hemosiderin deposits, presence of
osteoclast-like giant cells and reactive bone formation.
CGCRG has been first described by Jaffe in 1953 [5] and
accounts for approximately 7% of all benign tumours of the
jaws.[6]  It is usually appears as solitary, multilocular,
radiolucencies, located in the mandible ( anterior to the first
molars) and maxilla. It occurs at least twice as often in the
mandible than in the maxilla. CGCRG most commonly
occurs in patients under the age of 30, with a clear female
prevalence.[6] The aetiology of giant cell granuloma is
undefined; some describe it as an inflammatory proliferation,
some lesions behave as a neoplastic process in an aggressive
fashion. Jaffe considered this tumour as a locally reparative
reaction of the bone due to inflammation, local trauma or
haemorrhage. [5] In the literature there is little evidence of
any local reparative process.
The clinical behaviour of CGCG ranges from a slow
growing asymptomatic swelling to an aggressive lesion that
presents pain, local bone destruction, root resorption or tooth
displacement .Currently, clinical signs and symptoms,
radiological features and histological features are the main
criteria to differentiate between non-aggressive (indolent) and
aggressive lesions.
Aggressive lesions are characterized by one or more
of the following features: pain, paraesthesia, root resorption,
rapid growth, cortical perforation, and a high recurrence rate
after surgical curettage- between 37.5% and 70% [4, 7, 10]
and are mostly found in younger patients [2] are larger (over
5 cm)[1]. These aggressive type or recurrent lesions require
wide en-bloc resection that leads to major defects in the jaws
that can alter the facial contours [2, 3, 8] and necessitate
major reconstruction. Some surgeons use autogenous bone
grafts or vascularized fibula free flap for reconstruction of
extensive CGCG.[3, 8] Histologically there is no strict
criterion to differentiate between aggressive and non-
aggressive lesions, however the number and volume of giant
cells versus other components of the lesion might give an
indication on its clinical behaviour.[1, 2, 6, 10]
Non-aggressive lesions are usually slow growing,
symptom free and the treatment includes conservative
surgical procedures.
Although the majority of cases were asymptomatic,
the most common feature was a painless smooth swelling in
the face or in the oral cavity. The lesion does not invade the
perineural sheets so paresthesia is not usually observed in
these patients. The other symptoms and signs are facial
asymmetry, impaired nasal breathing, loosing or displacement
of teeth, and pathologic fracture.[6, 9]
CGCRGs usually present as an expansile radiolucency
(87.5%) in X-ray films, but radiologic features vary from ill-
defined destructive lesions to a well-defined, multilocular or
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unilocular appearance, with root resorption in 13.5% of the
lesions and displacement of teeth in 18.0%.
Histologically, multinucleated giant cells, in a cellular
vascular stroma, and often-new bone formation are
demonstrated. The osteoclast-like giant cells have a patchy
distribution and are usually associated with areas of
hemorrhage. Ultrastructurally, the proliferating cells include
spindle- shaped fibroblasts, myofibroblasts, and inflammatory
mononuclear cells.[2, 6]
Differential diagnosis should be considered:
Aneurysmal bone cyst, chondroblastoma, osteoblasto-
clastoma, ameloblastoma, fibroma non-ossificans, hyper-
parathyroidism, odontogenic cysts etc.
The treatment of CGCG of the jaws is performed
according to the following factors: aggressive versus non-
aggressive behaviour, location, size and radiographic
appearance. Surgical options range from large (en bloc
resection) to more conservative approaches (curettage).
The traditional therapy of CGCRG has been local
curettage( this has been associated with a high success rate-
80%), peripheral osteotomy, excision if needed reconstruction
by using an autologous  bone graft.[2, 6]
Surgical treatment of CGCRGs can be associated with
recurrence and serious facial mutilation and loss of teeth and
tooth germs. To avoid such disadvantages, a number of
alternative nonsurgical herapies including interferon alpha-
2a, calcitonin and intralesional corticosteroid injection have
been advocated for the management of CGCRG . Non-
surgical treatment of CGCRG is probably a good treatment
option for small slowly enlarging lesions. Successful
treatment of painful, large, and rapidly growing lesions is
more likely achieved by surgical removal. In the literature,
recurrence rates vary between 11% and 35%.[6]
CASE REPORT
We present 26 years old male  with  histopathologic
examination of the lesion reported as ‘giant cell reparative
granuloma’ of the mandible. On clinical examination the
patient was without subjective complaints. Biopsy specimen
taken from the lesion showed CGCG.
Radiografic imaging showed radiolucent lesion on
right side of lower jaw, well- defined, with resorption of roots
of tooth 46, unilocular in appearance (Fig. 1). The patient was
operated under general anaesthesia. The tumour mass was
removed through an intraoral approach and curettage with
peripheral ostectomy with preservation of the continuity of
the mandible with at least a 5 mm margin was performed.
Teeth 45 and 47 were extracted. The inferior alveolar nerve
was preserved. Immediate reconstruction was carried out for
this case with with autogenous bone graft from mental region
(Fig. 2).  The bone graft was fixed with four screws. (Fig. 3)
No complication was observed in terms of loss of teeth,
wound dehiscence, infection of the surgical site, graft
incorporation, fracture or loss of plates and screws and
necrosis of bone segments. Prosthetic rehabilitation with
implants will be perfomed.
RESULT:
At the 1-year clinical and radiological follow up there
was no sign of recurrence. The postoperative defect is fully
reconstructed. (Fig. 4)
DISCUSSION:
The true nature of CGCG remains speculative and
considerable controversy exists in the literature. Normally,
it is not considered an odontogenic lesion.[8] It has
been suggested that it might be an inflammatory lesion, a
reactive lesion, a true tumour, or an endocrine lesion.[5, 8]
One hypothesis suggests that CGCG belongs to the spectrum
of mesenchymal proliferative vascular primary jaw lesions.[8]
CGCG occurs predominantly in children or young adults,
with approximately 75% of cases presenting before 30 years
of age(our patient is 26 years of age), however it really can
occur at any age. Females are affected more frequently than
males, with a ratio of 2:1 [8] and more than 70% of CGCGs
occur in the mandible and less than 30% in the maxilla with
a preference for the anterior portions of both bones.[8] Due
to the special anatomical characteristics of the maxilla,
presentation, diagnosis, progress, management, and prognosis
of maxillary CGCG are different from that of mandibular
lesions: the cancellous nature of the maxilla and its thin
cortical plates allow the lesion to expand much earlier than
in the mandible.[8] The radiographic features of maxillary
CGCGs are variable and may be confused with those of other
lesions. They have been described as ranging from a
unilocular to a multilocular radiolucent appearance with well-
or illdefined borders.[10]
In the present case of CGCGs, there was a
multilocular, radiolucent non perforating lesion which do not
involved the cortical bone. Different authors [10] have
classified CGCG into two types, based on clinical and
radiographic features. The first is non-aggressive CGCG,
which is characterized by a slow, almost asymptomatic
growth that does not perforate the cortical bone or induce root
resorption and has a low tendency to recur. The second is
aggressive CGCG, which is characterized by pain, rapid
growth, expansion, and perforation of the cortical bone,
radicular resorption and a high tendency to recur. The
aggressive lesions are mostly found in younger patients.[2]
Aggressive lesions were also larger in size and from the
histological point of view they showed a larger fractional
surface area occupied by giant cells. In aggressive lesions also
can be found a higher number of giant cells. The most reliable
factors which relate to an increased risk of recurrence include
clinical activity of lesions (72% of recurrence in the
aggressive forms, 3% of recurrence in the non-aggressive
forms), young age, presence of perforation of cortical bone
and tumour size.[8]/ J of IMAB. 2013, vol. 19, issue 4/ http://www.journal-imab-bg.org 409
CONCLUSION:
Currently, no biological markers are known to predict
clinical behaviour, and standard histological techniques are
not helpful for the clinician to determine the prognosis.
Surgery has always been considered to be the traditional
treatment and it is still the most accepted. If soft tissues and
periosteum are preserved, and only the bony component is
excised, then it is possible to reconstruct the surgical defect
with autogenous bone grafts. By doing this bone continuity
is maintained and prosthetic rehabilitation via implants can
be safely performed.
Fig. 1. Radiografic imaging
showed radiolucent lesion on right side
of lower jaw, well- defined, with
resorption of roots of tooth 46
Fig. 2. Intraoperative fixation of the autogenic graft
with titanium plate and four screws
Fig. 3. Postoperative  X ray410 http://www.journal-imab-bg.org / J of IMAB. 2013, vol. 19, issue 4/
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Fig. 4.  Postoperative result after 1 year.
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